Enzo Biochem reported a 20% revenue decline in Q3 2025, with ongoing strategic reviews and a class-wide settlement following a cyber incident. Enzo Biochem, Inc. reported financial results for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback